The global InsurTech sector experienced a significant boost in funding during the third quarter of 2023, reaching a total of $1.1 billion. A major driver of this growth was the remarkable surge in Property & Casualty (P&C) InsurTech investment, which saw a quarter-on-quarter increase of 25.5%. However, despite the overall increase in funding, the average deal size fell to a six-year low of $10.3 million. Additionally, the Life & Health InsurTech investment slipped by 4.5% to $166.6 million. Let’s delve into the trends and implications of these developments.
P&C InsurTech Investment Soars
The quarter-on-quarter surge in P&C InsurTech investment has contributed significantly to the overall growth in funding. The increased interest in P&C InsurTech reflects the industry’s recognition of the potential for technological advancements in this sector.
Decrease in Average Deal Size
While overall funding increased, the average deal size saw a decline of 16.4% compared to the previous quarter. This reduction in average deal size can be attributed to various factors, including increased competition in the market and a shift towards smaller scale investments.
Despite the positive momentum in P&C InsurTech, investment in the Life & Health segment experienced a decline of 4.5% during Q3. This decline could be attributed to challenges faced by Life & Health InsurTech startups in attracting investors due to regulatory complexities and longer-term value realization.
Increase in InsurTech deal count
The InsurTech deal count experienced a significant increase from 97 in Q2 to 119 in Q3, marking the highest deal count since Q3 2022. This increase signals growing interest from investors in the InsurTech sector and highlights its potential for innovative disruption in the insurance industry.
Global Distribution of InsurTech Investments
The United States continues to dominate the global InsurTech deal share, accounting for 55.4% of investments in Q3 2023. This represents the highest level of investment dominance for the United States since Q1 2020, indicating the country’s strong position as a hub for InsurTech innovation.
Overview of Early-Stage InsurTech Funding
Early-stage InsurTech funding also witnessed a significant boost in Q3, increasing by 24.7% compared to the previous quarter. This increase in early-stage funding demonstrates growing investor confidence in the potential of emerging InsurTech startups to disrupt the traditional insurance landscape.
The Role of Re/insurers in InsurTech Investments
Re/insurers played a pivotal role in Q3 InsurTech funding, making a total of 34 investments. The majority of these investments (61.8%) fell into the early-stage category, highlighting re/insurers’ interest in nurturing and supporting early-stage InsurTech startups. This collaboration between traditional insurers and InsurTech innovators is crucial in leveraging technology to fortify the value of reinsurance.
Investments by trade players
Q3 witnessed a significant number of investments by industry players in the insurtech sector. Notably, there were 10 seed/angel-stage investments and 11 Series A investments made by industry players. This demonstrates the growing interest of established players in the insurance industry to partner with and invest in promising insurtech startups.
The surge in global InsurTech funding during Q3 2023, primarily driven by increased P&C InsurTech investment, indicates the growing importance of technology in the insurance sector. Despite a decline in the average deal size and Life & Health InsurTech investment, the increase in deal count and early-stage funding points towards a promising future for innovation in insurance. The dominance of the United States in InsurTech investments highlights the country’s role as a leader in the industry. It is clear that technology and new entrants will play a critical role in preserving and fortifying the value of reinsurance, opening up new opportunities for collaboration and disruption in the global insurance market.